← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
NDA · New Drug Application · Sponsor: HETERO LABS LTD III · Approved 2017-05-05
Drug application
- FDA Application #
NDA207315- Application type
- New Drug Application
- Brand name
- LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- HETERO LABS LTD III
- First approval
- 2017-05-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown